drugset / Trial / NCT00871806

Pharmacokinetics of Two Eletriptan Oral Formulations Given With and Without Water and the Commercial Tablet Formulation Given With Water

NCT00871806

Phase 1 Completed 20 enrolled Viatris Inc.
RandomizedCrossoverOpen-labelBasic science

Summary

The study will evaluate whether the blood concentrations of eletriptan administered using two test formulations of oral disintegrating tablets are comparable to those observed with the standard commercial tablet.

Timeline

Start
2009-04
Primary completion
2009-04
Completion
2009-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Eletriptan Small molecule 40 mg Oral

Indications

No indication recorded.